期刊
DRUG RESISTANCE UPDATES
卷 10, 期 3, 页码 109-120出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.drup.2007.03.001
关键词
tumor vasculature; angiogenesis; interstitial fluid pressure; tumor blood flow heterogeneities; tumor-associated fibroblasts; tumor-associated macrophages; anti-angiogenic; vascular-disrupting agents; caveolae; transcytosis
The identification of a critical role of tumour stroma in the regulation of tumour interstitial fluid pressure and the simultaneous discovery of the impact of anti-angiogenic drugs on tumour hemodynamics have provided new potential for improving tumour delivery of anti-cancer drugs. Here, we review the most recent studies investigating how tumour-associated fibroblasts and macrophages as well as the extracellular matrix itself may be targeted to facilitate delivery of both low-molecular weight drugs and macromolecules. In addition, we summarize the current understanding of the use of vasoactive compounds, radiotherapy and vascular-disrupting agents as potential adjuvants to maximize tumour delivery of anti-cancer drugs. The impact of these strategies on the diffusive and convective modes of drug transport is discussed in the light of Fick's and Starling's laws. Finally, we discuss how transcytosis through caveolae may also be exploited to optimize the selective delivery of conventional chemotherapy the subendothelial tumour cell compartment. (c) 2007 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据